ALTER.PA
Price:
$1.26
Market Cap:
$17.29M
Theradiag SA develops, manufactures, and markets in-vitro diagnostic products. It offers autoimmunity reagents; IMMUNO-TROL, a multi-parametric quality control tool; various instruments for autoimmunity and infectious diseases testing; SQA-V system, a semen analyzer; and V-Sperm for loading results, pictures, and videos of the samples into the computer. The company also provides instrumentation, including Theralis that integrates multiplex FIDIS immunofluorescence and ELISA; Theralis µ, a solution for medium sized laboratories; and FIDIS platform used in laboratory for analysis. In addition, it offers therapeutic drug monitoring services for treatment of chronic inflammatory diseases; and LI...[Read more]
Industry
Medical - Devices
IPO Date
2012-12-11
Stock Exchange
EURONEXT
Ticker
ALTER.PA
According to Theradiag SA’s latest financial reports and current stock price. The company's current PE Ratio is 42.00. This represents a change of -569.63% compared to the average of -8.94 of the last 4 quarters.
The mean historical PE Ratio of Theradiag SA over the last ten years is -23.03. The current 42.00 PE Ratio has changed -18338.07% with respect to the historical average. Over the past ten years (40 quarters), ALTER.PA's PE Ratio was at its highest in in the June 2023 quarter at 16.90. The PE Ratio was at its lowest in in the December 2020 quarter at -6962.36.
Average
-23.03
Median
-11.02
Minimum
-105.43
Maximum
30.88
Discovering the peaks and valleys of Theradiag SA PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 210.22%
Maximum Annual PE Ratio = 30.88
Minimum Annual Increase = -441.44%
Minimum Annual PE Ratio = -105.43
Year | PE Ratio | Change |
---|---|---|
2022 | -60.82 | 51.00% |
2021 | -40.28 | -61.80% |
2020 | -105.43 | -441.44% |
2019 | 30.88 | -372.36% |
2018 | -11.34 | 210.22% |
2017 | -3.65 | -72.79% |
2016 | -13.43 | 25.48% |
2015 | -10.70 | 48.34% |
2014 | -7.21 | -13.07% |
2013 | -8.30 | -62.76% |
The current PE Ratio of Theradiag SA (ALTER.PA) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-68.84
5-year avg
-37.40
10-year avg
-23.03
Theradiag SA’s PE Ratio is greater than Biosynex SA (-0.35), greater than Novacyt S.A. (-1.74), greater than Biophytis S.A. (-0.08), greater than Eurobio Scientific SA (38.41), greater than Genomic Vision SA (-0.04),
Company | PE Ratio | Market cap |
---|---|---|
-0.35 | $22.92M | |
-1.74 | $41.88M | |
-0.08 | $4.61M | |
38.41 | $254.64M | |
-0.04 | $693.19K |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Theradiag SA using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Theradiag SA or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is Theradiag SA's PE Ratio?
How is the PE Ratio calculated for Theradiag SA (ALTER.PA)?
What is the highest PE Ratio for Theradiag SA (ALTER.PA)?
What is the 3-year average PE Ratio for Theradiag SA (ALTER.PA)?
What is the 5-year average PE Ratio for Theradiag SA (ALTER.PA)?
How does the current PE Ratio for Theradiag SA (ALTER.PA) compare to its historical average?